Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 1

Status

Active not recruiting 6Recruiting 5Not yet recruiting 4Completed 4Terminated 1

Sponsor Class

INDUSTRY 4OTHER 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 4Gynecologic 1Breast 1

Conditions

Non Small Cell Lung Carcinoma NSCLC 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Endometrial Neoplasms 1Carcinoma 1Breast Neoplasms 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 252Magnetic Resonance Spectroscopy 244Cyclophosphamide 240Cisplatin 213Paclitaxel 206Radiotherapy 195Biopsy 171Gemcitabine 155Dexamethasone 148durvalumab 143atezolizumab 126Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 111Radiation 109Docetaxel 103Pemetrexed 102Etoposide 101fludarabine 97venetoclax 95Fluorouracil 92Capecitabine 92Radiosurgery 90Prednisone 89Oxaliplatin 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × CP protocol × 1 year × Clear all
NCT02453282 2026-05-12

MYSTIC

AstraZeneca

Phase 3 Active not recruiting
1,118 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT02542293 2026-05-01

NEPTUNE

AstraZeneca

Phase 3 Active not recruiting
953 enrolled 29 charts
Thoracic

Non Small Cell Lung Carcinoma NSCLC

NCT03003962 2026-03-11

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

AstraZeneca

Phase 3 Active not recruiting
669 enrolled 54 charts
Thoracic

Non Small Cell Lung Carcinoma NSCLC

NCT05201547 2025-12-04

DOMENICA

ARCAGY/ GINECO GROUP

Phase 3 Active not recruiting
260 enrolled
Gynecologic

Neoplasm Metastasis, Endometrial Neoplasms

NCT03519971 2025-10-28

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

AstraZeneca

Phase 3 Active not recruiting
328 enrolled 23 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡